Literature DB >> 7543742

Resection margin for squamous cell carcinoma of the esophagus.

S Tsutsui1, H Kuwano, M Watanabe, M Kitamura, K Sugimachi.   

Abstract

OBJECTIVE: The safe resection margin in esophagectomy for esophageal squamous cell carcinoma (SCC) was determined based on the extent of epithelial and subepithelial accessory lesions from the main lesions of esophageal SCC.
BACKGROUND: There have been many reports on the high incidence of a positive resection margin for esophageal cancer. Although there were some studies on the relationships of the proximal clearance to postoperative local recurrence, no pathologic study on the resection margin has been reported.
METHODS: Four hundred twenty specimens of a whole resected esophagus were examined histopathologically and the longitudinal length from the main lesion to the five types of accessory lesions was measured on microscopic slides.
RESULTS: Contiguous intraepithelial carcinoma existed in 69 (46%) of 150 sites of main lesions restricted to the mucosa or submucosa and subepithelial lesions existed in 131 (54%) of 245 sites and 82 (55%) of 150 sites of main lesions invading an adventitia and into neighboring structures, respectively. The risk of a positive resection margin due to subepithelial lesions was below 5% at 10 mm in the main lesion, restricted to the submucosa or the muscularis propria, and at 30 mm in the main lesion, invading the adventitia in the potentially curative operation cases.
CONCLUSION: These clearances of the resection margin, in which the risk of a positive resection margin is below 5%, are acceptable, although these clearances should only be accepted after the extent of epithelial accessory lesions is accurately determined by the Lugol's stain method.

Entities:  

Mesh:

Year:  1995        PMID: 7543742      PMCID: PMC1234778          DOI: 10.1097/00000658-199508000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  31 in total

1.  Superficial esophageal carcinoma: a clinicopathological review of 59 cases.

Authors:  H Yoshinaka; H Shimazu; T Fukumoto; M Baba
Journal:  Am J Gastroenterol       Date:  1991-10       Impact factor: 10.864

2.  Histopathological evaluation of oesophageal carcinoma: the significance of venous invasion.

Authors:  P H Theunissen; F Borchard; D C Poortvliet
Journal:  Br J Surg       Date:  1991-08       Impact factor: 6.939

3.  Prognostic significance of intramural metastasis in patients with esophageal carcinoma.

Authors:  K Takubo; K Sasajima; K Yamashita; Y Tanaka; K Fujita
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

4.  Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma.

Authors:  K Sugimachi; H Matsuoka; S Ohno; M Mori; H Kuwano
Journal:  Br J Surg       Date:  1988-11       Impact factor: 6.939

5.  Superficial esophageal carcinoma. Surgical treatment and the results.

Authors:  H Kato; Y Tachimori; H Watanabe; H Yamaguchi; T Ishikawa; M Itabashi
Journal:  Cancer       Date:  1990-12-01       Impact factor: 6.860

6.  Early diagnosis of esophageal cancer. Analysis of 11 cases of esophageal mucosal cancer.

Authors:  A Misumi; K Harada; A Murakami; K Arima; H Kondo; M Akagi; Y Yagi; T Ikeda; Y Kobori; H Matsukane
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

7.  Lugol stain for intraoperative determination of the proximal surgical margin of the esophagus.

Authors:  K Sugimachi; S Tsutsui; K Kitamura; M Morita; M Mori; H Kuwano
Journal:  J Surg Oncol       Date:  1991-04       Impact factor: 3.454

8.  Clinicopathologic study of early stage esophageal carcinoma.

Authors:  K Sugimachi; S Ohno; H Matsuda; M Mori; H Matsuoka; H Kuwano
Journal:  Surgery       Date:  1989-06       Impact factor: 3.982

9.  Long-term effects of hyperthermia combined with chemotherapy and irradiation for the treatment of patients with carcinoma of the esophagus.

Authors:  K Sugimachi; H Matsuda; S Ohno; A Fukuda; H Matsuoka; M Mori; H Kuwano
Journal:  Surg Gynecol Obstet       Date:  1988-10

10.  Lugol-combined endoscopic detection of minute malignant lesions of the thoracic esophagus.

Authors:  K Sugimachi; S Ohno; H Matsuda; M Mori; H Kuwano
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

View more
  11 in total

1.  ACP. Best Practice No 155. Guidelines for handling oesophageal biopsies and resection specimens and their reporting.

Authors:  N B Ibrahim
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

2.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

3.  Multiphoton microscopy for label-free identification of intramural metastasis in human esophageal squamous cell carcinoma.

Authors:  Jian Xu; Deyong Kang; Yaping Zeng; Shuangmu Zhuo; Xiaoqin Zhu; Liwei Jiang; Jianxin Chen; Jiangbo Lin
Journal:  Biomed Opt Express       Date:  2017-06-21       Impact factor: 3.732

4.  Unexpected Microscopically Positive Proximal Resection Margins in Esophageal Squamous Cell Carcinoma After Chemoradiotherapy: Predictors and Prognostic Significance.

Authors:  Chien-Hung Chiu; Yin-Kai Chao; Yu-Wen Wen; Hsien-Kun Chang; Chen-Kan Tseng; Yun-Hen Liu
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

5.  Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.

Authors:  Talha Shaikh; Mark A Zaki; Michael M Dominello; Elizabeth Handorf; Andre A Konski; Steven J Cohen; Anthony Shields; Philip Philip; Joshua E Meyer
Journal:  Acta Oncol       Date:  2015-11-19       Impact factor: 4.089

6.  DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer.

Authors:  S Münch; M Oechsner; S E Combs; D Habermehl
Journal:  Radiat Oncol       Date:  2017-08-15       Impact factor: 3.481

Review 7.  The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis.

Authors:  Rudi Apolle; Maximilian Rehm; Thomas Bortfeld; Michael Baumann; Esther G C Troost
Journal:  Clin Transl Radiat Oncol       Date:  2017-03-21

8.  Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation.

Authors:  Antoine Schernberg; Laurence Moureau-Zabotto; Eleonor Rivin Del Campo; Alexandre Escande; Michel Ducreux; France Nguyen; Diane Goere; Cyrus Chargari; Eric Deutsch
Journal:  Oncotarget       Date:  2017-02-14

9.  Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer.

Authors:  Melanie Machiels; Maurits L van Montfoort; Nikki B Thuijs; Mark I van Berge Henegouwen; Tanja Alderliesten; Sybren L Meijer; Jeanin E van Hooft; Maarten C C M Hulshof
Journal:  Radiat Oncol       Date:  2019-12-04       Impact factor: 3.481

Review 10.  What Is the Appropriate Clinical Target Volume for Esophageal Squamous Cell Carcinoma? Debate and Consensus Based on Pathological and Clinical Outcomes.

Authors:  Dali Han; Yinping Yuan; Xuqing Song; Yonghua Yu; Jinming Yu
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.